Notice of Change in Executive Summary of RFA-DA-08-002, Criminal Justice Drug Abuse Treatment Studies 2 (CJ-DATS 2) (U01)

Notice Number: NOT-DA-08-020

Key Dates
Release Date: August 2, 2007

Issued by
National Institute on Drug Abuse (NIDA), (http://www.nida.nih.gov)

The purpose of this Notice is to delete “An institution may submit only one application in response to this RFA” from the Executive Summary of RFA-DA-08-002. The Executive Summary should read as follows:

Executive Summary

  • The National Institute on Drug Abuse (NIDA) invites cooperative agreement applications to participate as Research Centers in the second phase of the national Criminal Justice Drug Abuse Treatment Studies (CJ-DATS 2).  The goal of this cooperative research program is to develop and test systems-level models that integrate public health and public safety approaches for criminal justice-involved adults and adolescents with drug abuse and addictive disorders.
  • NIDA intends to commit approximately $5.6 million in total costs [Direct plus Facilities and Administrative (F & A) costs] in FY 2008 to fund eight to ten new and/or competing continuation grants in response to this RFA.  Additional funds are being sought from other sources
  • This funding opportunity will use the NIH Cooperative Research Project Grant (U01) award mechanism.
  • Eligible organizations include: Public/State Controlled Institution of Higher Education; Private Institution of Higher Education; Nonprofit with 501(c)(3) IRS Status (Other than Institution of Higher Education); Nonprofit without 501(c)(3) IRS Status (Other than Institution of Higher Education); Small Business; For-Profit Organization (Other than Small Business); State Government; U.S. Territory or Possession; Indian/Native American Tribal Government (Federally Recognized); Indian/Native American Tribal Government (Other than Federally Recognized); Indian/Native American Tribally Designated Organization; Non-domestic (non-U.S.) Entity (Foreign Organization); Hispanic-serving Institution; Historically Black Colleges and Universities (HBCUs); Tribally Controlled Colleges and Universities (TCCUs); Alaska Native and Native Hawaiian Serving Institutions; Regional Organization; Other(s): Eligible agencies of the Federal government; Faith-based or community based organizations.)
  •  Eligible Project Directors/Principal Investigators (PDs/PIs). Individuals with the skills, knowledge, and resources necessary to carry out the proposed research are invited to work with their institution/organization to develop an application for support. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH support.
  • Number of PDs/PIs. More than one PD/PI, or multiple PDs/PIs, may be designated on the application.
  • Application and Submission Information: Applicants may submit more than one application, provided each application is scientifically distinct.   
  • Resubmissions (formerly “revisions/amendments’) will not be accepted under this RFA.  At this time it is not known whether or not this RFA will be reissued.  
  • See Section IV.1 for application materials.
  • Telecommunications for the hearing impaired is available at: TTY 301-451-5936

Inquiries

Direct inquiries regarding this Notice to:  

Akiva M. Liberman, Ph.D.
Services Research Branch
Division of Epidemiology, Services and Prevention Research
National Institution on Drug Abuse/NIH/DHHS
6001 Executive Boulevard, Room 5194, MSC 9589
Bethesda, MD  20892-9589
TEL:  (301) 402-0807
FAX:  (301) 443-2636
Email:  [email protected]